Integra LifeSciences Holdings (IART)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	1,058,040	1,027,230	1,051,260	1,029,480	1,161,500	1,196,450	1,137,410	1,066,050	1,153,720	1,103,780	1,032,380	1,039,080	1,237,200	1,152,100	966,222	1,008,670	858,168	883,813	868,672	822,686
Total current liabilities	US$ in thousands	306,980	355,712	377,496	282,293	320,906	304,452	295,596	315,833	340,021	332,858	318,756	412,301	401,013	255,146	212,415	246,485	331,309	302,641	315,111	288,106
Current ratio		3.45	2.89	2.78	3.65	3.62	3.93	3.85	3.38	3.39	3.32	3.24	2.52	3.09	4.52	4.55	4.09	2.59	2.92	2.76	2.86

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,058,040K ÷ $306,980K
= 3.45

Integra Lifesciences Holdings Corp has exhibited fluctuations in its current ratio over the past eight quarters, ranging from a low of 2.78 in Q2 2023 to a high of 3.93 in Q3 2022. The company's current ratio measures its ability to meet its short-term obligations with its current assets.

A current ratio above 1 indicates that the company has more current assets than current liabilities, providing a margin of safety in meeting its short-term obligations. Integra Lifesciences has consistently maintained a current ratio above 2 in all quarters, reflecting a strong liquidity position.

The current ratio peaked at 3.93 in Q3 2022, indicating a significant cushion of current assets to cover short-term liabilities. The subsequent decrease in Q4 2022 to 3.62 was followed by further fluctuations, with Q2 2023 recording the lowest current ratio of 2.78 during the period under review.

Despite the fluctuations, the current ratio remains generally healthy, with an average of approximately 3.43 over the eight quarters. Investors and stakeholders should continue to monitor the company's liquidity position, considering the variations in the current ratio over time.